Dose Range Study of CD5789 in Acne Vulgaris
Public ClinicalTrials.gov record NCT01616654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of different concentrations of CD5789 cream in participants with acne vulgaris for the purpose of dose identification.
Study identification
- NCT ID
- NCT01616654
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 304 participants
Conditions and interventions
Conditions
Interventions
- CD5789 25 µg/g cream Drug
- CD5789 50 µg/g cream Drug
- CD5789 100 µg/g cream Drug
- Tazarotene 0.1% gel Drug
- Vehicle cream Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2012 (Actual)
- Primary completion
- Jul 24, 2013 (Actual)
- Completion
- Jun 12, 2014 (Actual)
- Last update posted
- Sep 20, 2021
2012 – 2014
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| Parexel Early Phase | Glendale | California | 91206 | — |
| Odyssey Medispa | Marina del Rey | California | 90292 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| FXM Research Corp Miami | Miami | Florida | 33175 | — |
| FMX Research Miramar | Miramar | Florida | 33027 | — |
| Meda Phase, Inc | Newnan | Georgia | 30263 | — |
| Deaconess Clinic, Inc. | Evansville | Indiana | 47713 | — |
| Dermatology Specialists PC | Louisville | Kentucky | 40202 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Zoe Drealos, MD | High Point | North Carolina | 27262 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| Central Sooner Research | Norman | Oklahoma | 73069 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Palmetto Clinical Trial Services, LLC | Greenville | South Carolina | 29607 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Suzanne Bruce and Associates P.A. The Center for Skin Research | Houston | Texas | 77056 | — |
| Stephen Miller MD | San Antonio | Texas | 78229 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Dermatology Research Center | Salt Lake City | Utah | 84124 | — |
| The Education & Research Foundation, Inc. | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01616654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01616654 live on ClinicalTrials.gov.